2-Methyl-4-(trifluoromethyl)thiazol-5-ylamine, 95.0%, 250mg

1-Oxo-1H-isochromene-4-carboxylic acid, 95.0%, 1g

3,4-Dimethoxybenzaldehyde, min. 99%, for synthesis, 100 g, plastic packaging.

Ascorbic acid, 99.00%, 500g

Bicyclo[2.2.1]heptan-1-ol, 97%, 50mg

5-Nitrobenzofuran, 95.0%, 1g

3,5-Dimethylisoxazole-4-boronic acid, 98.0%, 10g

5-Fluoro-3,3-bis(4-fluorophenyl)benzo[c][1,2]oxaborol-1(3H)-ol>98.0%(HPLC)100mg

Fmoc-3-(1-Morpholinyl)-L-Ala-OH, 95.0%, 100mg

5-Methyl-nicotinic acid, 97.0%, 1g

tert-Butyl (3-methyl-2-nitrophenyl)carbamate, 95.0%, 5g

(S)-4-BOC-3-((S)-1-HYDROXYETHYL)MORPHOLINE, 97.0%, 100mg

2-(4-((4-Bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g